| abstract |
The present invention has the structure XXCCXXXXXXXCXXXCXXXXXXQXXCXXXCXCXXXXXXXCXXXXXX, Relates to cysteine-containing peptides having the structure XXCCXXXXXXXCXXXCXXXXXXXXXCXXXCXCXXXXTXXCXXXXXX and the structure XXCCXXXXXXXCXXXCXXXXXXXXXXCXXXCXCXXXXXXXXCXXXXXX, where X is any of the naturally occurring amino acids and the nucleic acid sequence encoding the peptide Incorporated vectors, as well as pharmaceutical compositions containing the above peptides and their use as pharmaceuticals, particularly cancer treatment. |